SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Celestial Biolabs - Quaterly Results

02 Sep 2022 Evaluate
The revenue slipped marginally during the March 2022 quarter. A decline of about Rs. 0.63 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2022 is Rs. -2.75 millions as compared to Net Loss of Rs. -0.78 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 further decreased to -2.68% as compared to -0.69% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 0.63 0.00 0.00 1.48 0.00 0.00 1.48 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.30 0.00 0.00 0.30 0.00
PBIDT -2.68 -0.69 288.41 -3.79 -1.33 184.96 -3.79 -1.33 184.96
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -2.68 -0.69 288.41 -3.79 -1.33 184.96 -3.79 -1.33 184.96
Depreciation 0.07 0.09 -22.22 0.30 0.39 -23.08 0.30 0.39 -23.08
PBT -2.75 -0.78 252.56 -4.09 -1.72 137.79 -4.09 -1.72 137.79
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -2.75 -0.78 252.56 -4.09 -1.72 137.79 -4.09 -1.72 137.79
Equity 225.86 225.86 0.00 225.86 225.86 0.00 225.86 225.86 0.00
PBIDTM(%) -425.40 0.00 0.00 -256.08 0.00 0.00 -256.08 0.00 0.00

Celestial Biolabs Share Price

2.43 0.00 (0.00%)
11-Mar-2020 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×